Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study
KP ENRICH
1 other identifier
interventional
1,007
1 country
2
Brief Summary
The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (HbA1c) levels among adults with type 2 diabetes mellitus with glycemic control that is above target level. The main study aims are to:
- 1.To evaluate whether providing monthly financial support for home-delivered healthy food vs. only free food delivery through the Instacart platform reduces glycosylated hemoglobin levels within 6 months among Medi-Cal-insured Kaiser Permanente adult members with diabetes mellitus and suboptimal glycemic control.
- 2.To evaluate whether providing monthly financial support for home-delivered healthy food vs. only free food delivery through the Instacart platform reduces medical resource utilization within 6 months among Medi-Cal-insured Kaiser Permanente adult members with diabetes mellitus and suboptimal glycemic control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus-type-2
Started Oct 2023
Typical duration for not_applicable diabetes-mellitus-type-2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 12, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedStudy Start
First participant enrolled
October 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedJanuary 8, 2026
December 1, 2025
2.2 years
September 12, 2023
January 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
6-month change in glycosylated hemoglobin level
Baseline glycosylated hemoglobin will be ascertained using routine laboratory tests in the electronic health record prior to enrollment. Participants will complete glycosylated hemoglobin testing 6 months after enrollment.
6 months after enrollment
Secondary Outcomes (8)
12-month change in glycosylated hemoglobin level
12 months after enrollment
Percentage of participants with glycosylated hemoglobin <7.5%
6- and 12-months after enrollment
All-cause hospitalizations or emergency department visits
3-, 6-, and 12-months after enrollment
Change in self-reported level of food security
6- and 12-months after enrollment
Change in self-reported level of nutrition security
6- and 12-months after enrollment
- +3 more secondary outcomes
Study Arms (2)
Financial Support and Free Delivery
EXPERIMENTALThe intervention group will receive monthly financial support for healthy food items along with free home delivery through the Instacart platform.
Free Delivery
EXPERIMENTALThe control group will receive only free home delivery through the Instacart platform.
Interventions
Participants will have home delivery and service fees waived for 4 orders per month through the Instacart platform for a duration of 6 months.
Participants will receive monetary support to spend on healthy food items (e.g., vegetables and fruit) through the Instacart platform for a duration of 6 months and have home delivery and service fees waived for 4 orders per month through the Instacart platform for a duration of 6 months.
Eligibility Criteria
You may qualify if:
- Adults aged ≥18 years old at enrollment
- Active membership in Kaiser Permanente with Medi-Cal insurance and no additional private or commercial insurance
- Diagnosis of Type II diabetes mellitus (not including Type I diabetes mellitus or gestational diabetes mellitus)
- At least 2 outpatient glycosylated hemoglobin measures ≥7.5% in the prior 18 months
- Current access to the internet via computer or mobile device
- No interpreter needed
You may not qualify if:
- Advanced or end-stage kidney disease (estimated glomerular filtration rate ≤15 ml/min/1.73m\^2 or receiving outpatient dialysis or having a prior kidney transplant)
- Known pregnancy at time of identification
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kaiser Permanente Southern California Department of Research & Evaluation
Pasadena, California, 91101, United States
Kaiser Permanente Northern California Division of Research
Pleasanton, California, 94588, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia L Nau, PhD
Kaiser Permanente
- PRINCIPAL INVESTIGATOR
Richard Grant, MD, MPH
Kaiser Permanente
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2023
First Posted
September 29, 2023
Study Start
October 1, 2023
Primary Completion
December 27, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
January 8, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share